These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15743894)

  • 1. Severe myopathy and possible hepatotoxicity related to daptomycin.
    Echevarria K; Datta P; Cadena J; Lewis JS
    J Antimicrob Chemother; 2005 Apr; 55(4):599-600. PubMed ID: 15743894
    [No Abstract]   [Full Text] [Related]  

  • 2. Daptomycin-induced rhabdomyolysis and acute liver injury.
    King ST; Walker ED; Cannon CG; Finley RW
    Scand J Infect Dis; 2014 Jul; 46(7):537-40. PubMed ID: 24801642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin-associated myopathy induced by concomitant administration of mirabegron.
    Hagiya H; Kokado R; Okuno H; Tomono K
    Infection; 2019 Apr; 47(2):331-332. PubMed ID: 30430398
    [No Abstract]   [Full Text] [Related]  

  • 4. Muscle pain associated with daptomycin.
    Veligandla SR; Louie KR; Malesker MA; Smith PW
    Ann Pharmacother; 2004 Nov; 38(11):1860-2. PubMed ID: 15367725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.
    Golightly LK; Barber GR; Barron MA; Page RL
    Drug Metabol Drug Interact; 2013; 28(1):49-58. PubMed ID: 23314530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Hepatotoxicity Associated With Daptomycin: A Case Report and Literature Review.
    Mo Y; Nehring F; Jung AH; Housman ST
    J Pharm Pract; 2016 Jun; 29(3):253-6. PubMed ID: 26763341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database.
    Yamada T; Mitsuboshi S; Suzuki K; Nishihara M; Uchiyama K
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):268-272. PubMed ID: 34117712
    [No Abstract]   [Full Text] [Related]  

  • 8. [The second life of daptomycin: analysis of a successful come-back].
    Decousser JW; Doucet Populaire F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe daptomycin-induced myopathy].
    Ferrera C; Vilacosta I; Vivas D; Olmos C
    Med Clin (Barc); 2012 Jun; 139(3):138-9. PubMed ID: 22285497
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhabdomyolysis during therapy with daptomycin.
    Papadopoulos S; Ball AM; Liewer SE; Martin CA; Winstead PS; Murphy BS
    Clin Infect Dis; 2006 Jun; 42(12):e108-10. PubMed ID: 16705566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report and cohort analysis of drug-induced liver injury associated with daptomycin.
    Bohm N; Makowski C; Machado M; Davie A; Seabrook N; Wheless L; Bevill B; Clark B; Kyle TR
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4902-3. PubMed ID: 24820087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of daptomycin in patients with renal impairment].
    Azanza JR; Quetglas EG
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():55-9. PubMed ID: 21477705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible daptomycin-induced organizing pneumonia].
    Søndergaard TS; Schumacher H; Norup K
    Ugeskr Laeger; 2010 Aug; 172(32):2172-4. PubMed ID: 20696120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin.
    Hagiya H; Hasegawa K; Asano K; Terasaka T; Kimura K; Nada T; Nakamura E; Waseda K; Hanayama Y; Otsuka F
    Intern Med; 2015; 54(5):525-9. PubMed ID: 25758082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin-induced pulmonary infiltrates with eosinophilia.
    Shinde A; Seifi A; DelRe S; Moustafa Hussein WH; Ohebsion J
    J Infect; 2009 Feb; 58(2):173-4. PubMed ID: 19046602
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases.
    Miller BA; Gray A; Leblanc TW; Sexton DJ; Martin AR; Slama TG
    Clin Infect Dis; 2010 Jun; 50(11):e63-8. PubMed ID: 20420515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic pneumonia induced by daptomycin.
    Hayes D; Anstead MI; Kuhn RJ
    J Infect; 2007 Apr; 54(4):e211-3. PubMed ID: 17207858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of high dose (≥8 mg/kg/day) daptomycin].
    Parra-Ruiz J; Peña-Monje A; Tomás-Jiménez C; Pomares-Mora J; Hernández-Quero J
    Enferm Infecc Microbiol Clin; 2011; 29(6):425-7. PubMed ID: 21501905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute myopathy induced by minocycline.
    Narváez J; Vilaseca-Momplet J
    Am J Med; 2004 Feb; 116(4):282-3. PubMed ID: 14969661
    [No Abstract]   [Full Text] [Related]  

  • 20. Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports.
    Phillips J; Cardile AP; Patterson TF; Lewis JS
    Scand J Infect Dis; 2013 Oct; 45(10):804-8. PubMed ID: 23826793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.